Silvestre Geovana F G, Lucena Renally P, Oliveira Genil D, Pereira Helimarcos N, Dias Jhonatta A B, Souza Ivone A, Alves Harley S
Post-graduation Program of Pharmaceuticals Sciences, State University of Paraíba, Campina Grande 58429-500, Brazil.
Department of Pharmacy, State University of Paraíba, Campina Grande 58429-500, Brazil.
Pharmaceutics. 2021 May 18;13(5):743. doi: 10.3390/pharmaceutics13050743.
This work aimed to carry out a study of by investigating its chemical composition and pharmacological potential. From the dichloromethane phase (Dic-Ac) of the stems, three compounds were identified: cayaponoside C (Ac-1), cabenoside C (Ac-2) and fevicordin C glucoside (Ac-3), being last identified for the first time as a natural product. These compounds were obtained by chromatographic methods and their structures were elucidated by means of spectroscopic analysis of IR, MS and NMR. In the quantification of Dic-Ac, it was possible to observe the presence of 7% of cayaponoside C. Dic-Ac showed significant toxicity for in vivo tests, with macroscopic and biochemical changes. The anti-inflammatory activity of Dic-Ac was investigated using the paw edema model. A decrease in inflammatory signs was observed in the first 5 h and the most effective dose in reducing edema with was 7.5 mg kg (66.6%). Anti-tumor activity of Dic-Ac was evaluated by Ehrlich's carcinoma model, which showed inhibition rate of 78.46% at 15 mg kg dosage. The phytochemical investigation, together with the biological tests carried out in this study, demonstrated that is a promising species in the search for therapeutics, since it contains substances with high pharmacological potential in its composition.
这项工作旨在通过研究其化学成分和药理潜力来开展一项关于[具体研究对象未明确]的研究。从[具体植物名称未明确]茎的二氯甲烷相(Dic - Ac)中,鉴定出三种化合物:cayaponoside C(Ac - 1)、cabenoside C(Ac - 2)和fevicordin C葡萄糖苷(Ac - 3),其中最后一种化合物首次被鉴定为天然产物。这些化合物通过色谱方法获得,其结构通过红外光谱(IR)、质谱(MS)和核磁共振(NMR)光谱分析得以阐明。在对Dic - Ac的定量分析中,观察到存在7%的cayaponoside C。Dic - Ac在体内试验中显示出显著毒性,伴有宏观和生化变化。使用爪肿胀模型研究了Dic - Ac的抗炎活性。在最初5小时内观察到炎症体征有所减轻,减轻水肿的最有效剂量为7.5毫克/千克(66.6%)。通过艾氏腹水癌模型评估了Dic - Ac的抗肿瘤活性,在15毫克/千克剂量下显示出78.46%的抑制率。本研究中的植物化学研究以及生物学试验表明,[具体植物名称未明确]是寻找治疗药物的一个有前景的物种,因为其成分中含有具有高药理潜力的物质。